Tandem Diabetes Care
TNDM
#5711
Rank
โ‚น124.20 B
Marketcap
โ‚น1,780
Share price
-5.58%
Change (1 day)
9.47%
Change (1 year)
Categories

P/E ratio for Tandem Diabetes Care (TNDM)

P/E ratio as of November 2026 (TTM): -20.8

According to Tandem Diabetes Care 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -20.7527. At the end of 2022 the company had a P/E ratio of -30.6.

P/E ratio history for Tandem Diabetes Care from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-30.6-104.88%
2021627-480.18%
2020-16521.77%
2019-1351166.64%
2018-10.77214.82%
2017-0.1462-81.41%
2016-0.7867-83.15%
2015-4.6725.7%
2014-3.71-45.95%
2013-6.87

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
42.5-304.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
25.4-222.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ICU Medical
ICUI
153-835.17%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
31.7-252.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Insulet
PODD
24.6-218.45%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.